Tevogen Bio Holdings Inc. (TVGN)
Healthcare
Biotechnology
7.00 $
-0.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Tevogen Bio Holdings Inc. (TVGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| -5.3 | -8.7 | -8.2 | -12 | -12 | |
| 0.0 | 0.2 | 0.4 | 0.4 | 0.5 | |
| 0.6 | 4.6 | 0.0 | 41 | 16 | |
| -1.2 | -0.1 | 0.3 | 0.0 | -2.7 | |
| 0.1 | 0.5 | 0.1 | 0.0 | 0.1 | |
| -0.1 | -0.5 | -0.1 | – | -0.1 | |
| – | 0.0 | -343 | – | – | |
| 13 | 0.0 | 4.0 | 1.0 | 3.4 | |
| 13 | 7.5 | 3.9 | 12 | 12 | |
| 7.1 | -1.6 | -4.4 | 0.2 | -0.7 | |
| -5.4 | -9.1 | -8.3 | -12 | -12 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.